Trial Profile
An observational prospective study to assess Raltegravir-Etravirine Dual Combination as an Maintenance Regimen in HIV-1-Infected Patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Mar 2018
Price :
$35
*
At a glance
- Drugs Etravirine (Primary) ; Raltegravir (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 29 Mar 2018 New trial record